Arrakis Raises $30.0M Series A Funding

Transcripta Bio

We are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel. With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. Our Drug-Gene Atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. Our proprietary artificial intelligence modeling suite, Conductor AI, used our Drug-Gene Atlas to discover and predict the effects of new drugs at transcriptome scale.

1872

1872 is an AI-native steel fabrication company developing fully automated, lights-out factories capable of producing finished steel components directly from CAD to completed parts. Our mission is to remove the supply chain bottlenecks limiting America’s infrastructure by rebuilding heavy manufacturing from first principles. Founded by SpaceX alumni who scaled some of the most demanding production and software systems in the world, 1872 applies first-principles thinking, automation, and factory software to one of America’s most critical industries. Our prototype factory in Cincinnati, Ohio will serve as the proving ground for a new model of steel manufacturing: fast, scalable, and software native. 1872 is building a new foundation for American manufacturing and we’re hiring, join our team → https://1872.ai/careers